• 생물정신의학
• /
• 제16권4호
• /
• pp.229-237
• /
• 2009

Recent Korean statistics show that a Korean woman can now expect to live until her mid-80s, which implies living at least one-third of her life after menopause. The menopausal transition is typically marked by intense hormonal fluctuations, accompanied by sleep disturbance, vasomotor symptoms(e.g., hot flashes, night sweats), increased risk for osteoporosis, cardiovascular disease, and developing depression as well as mood disturbances. These symptoms can affect a woman's quality of life negatively. Therefore, a comprehensive understanding of the accurate detection and appropriate treatment of various menopause-related symptoms including depression in the menopausal transitions and postmenopause is mandatory. This review primarily focused on the current knowledge about the treatment of menopause-related depression.

• International journal of advanced smart convergence
• /
• 제10권3호
• /
• pp.214-224
• /
• 2021

We was confirmed that the antler extract increases the expression of marker genes expressed in the process of bone formation, and that the effect on the increase in the expression of the gene is further increased by fermentation of the antler extract. In addition, the mouse model in which menopausal was induced by ovary extraction significantly reduced the movement distance and exercise time of mice compared to the control group. But the decrease was somewhat alleviated by the administration of the antler extract, and completely restored when the fermented antler extract was administered. In the menopause-induced mice, the body weight ratio of heart, liver, and spleen weights increased compared to the control group, but the antler extract and the antler ferment extract restored the body weight ratio of various organ weights to the level of the control group in the menopause-induced mice. Consequently, this has led to mitigating changes in the metabolism affected by menopause.

• 지역사회간호학회지
• /
• 제7권1호
• /
• pp.129-137
• /
• 1996

The purpose of this study is to examine the medicalizing process of menopanse with literature review, and then is to explore the knowledge of 'menopausal syndrome' critically, focused on four critics on the biomedical model which were suggested by Mishler. Although menopause is a natural biological phenomenon, the view of many medical researchers and practitioners is that menopause is a disease. After synthetic estrogen was developel in 1938, physicians did agree on two basic assumptions : menopausal women should be managed by physicians, and medical intervention should be given. Menopouse was defined as a deficiency disease (estrogen difficiency) by Wilson in 60's and is redefined as a cause of disease(for example, osteoporosis, heart disease) at the present. But the other view of non-medical researcher is that 'menopausal syndrome' as a disease is constructed medically. It was reported that Only hot flush and sweating of physical symptoms experienced by menopausal women, were associated with menopause. Symptoms of menopausal syndrome are also related with symptons of aging. So, it cann't conclude that menopausal syndrome is resulted from menopause, and it cann't be only explained that menopausal syndrome is related causally to estrogen deficiency, and only treatment by ERT or HRT is best relevant. It cann't assume that menopausal syndrome is a common phenomenon to all menopause women, because culture affected on women's experience of menopause.

• 수면정신생리
• /
• 제9권2호
• /
• pp.96-99
• /
• 2002

Menopause, the cessation of menstruation caused by the decline in estrogen production, occurs in 95% of women between 40 and 60 years. Sleep disturbance is a frequent complaint during the perimenopause period. In contrast to premenopausla women, menopausal women experience more reduction in the total sleep hours and report more sleep disturbances, such as insomnia, noctiria and sleep disordered breathing. But the prevalence, etiology and treatment of sleep disturbances in menopause are still controversal. So further investigations are required to elucidate the factors that account for the differences in sleep disturbance between premenopausal and postmenopausal women. There are suggestive data that estrogen and progesterone deficiency may increase the susceptibility for sleep disorder in menopause. Furthermore, there are suggestive evidence from observational studies and a limited number of randomized, controlled trials that hormone replacement therapy after menopause improves sleep. However, the clinical relevance of hormone replacement therapy is unproved. So the overall benefit of hormonal replacement in postmenopausal women with sleep related disorders should be individualized to avoid potential side effects. Several studies evaluated the role of melatonin, because this hormone has effects on core body temperature & insomnia. But the exact dosage and the effects of long-term use of melatonin are unclear. So, caution is indicated in melatonin administration.

• 대한간호학회지
• /
• 제52권2호
• /
• pp.214-227
• /
• 2022

Purpose: This study was aimed at investigating the incidence and risk factors of dyslipidemia in menopausal women using a Korean community-based longitudinal study. Methods: The subjects were 245 postmenopausal women without dyslipidemia who had participated in the Ansan-Ansung cohort study from 2001~2002 (baseline) to 2015~2016 (seventh follow-up visit). The dyslipidemia incidence was measured as incidence proportion (%) and incidence rate per 100 person-years. The predictors of developing dyslipidemia were analyzed with Cox's proportional hazard model. Results: The incidence of new dyslipidemia during the follow-up period was 78.4% (192 patients), and 11.9 per 100 person-years. Mean duration from menopause to developing dyslipidemia was 5.3 years in new dyslipidemia cases. The triglyceride/high density lipoprotein (TG/HDL-C) ratio at baseline (hazard ratio = 2.20; 95% confidence interval = 1.39~3.48) was independently associated with developing dyslipidemia. Conclusion: Dyslipidemia occurs frequently in postmenopausal women, principally within five years after menopause. Therefore, steps must be taken to prevent dyslipidemia immediately after menopause, particularly in women with a high TG/HDL-C ratio at the start of menopause.

• 동서간호학연구지
• /
• 제30권1호
• /
• pp.60-69
• /
• 2024

Purpose: This study was conducted to determine the impact of premature menopause (PM) on metabolic syndrome and its components to determine its contribution to the health of Korean women undergoing natural menopause. Methods: This study used data from the 4^th to 8^th National Health and Nutrition Examination Survey (2007~2021). A total of 11,989 women aged 30 to 65 who responded to questions about their current menstrual status, natural menopause status and its age. Complex sample multivariate Cox proportional hazards regression analysis was used. Results: Compared with women with late menopause, women with PM had a 1.34 times higher risk of developing metabolic syndrome. Excluding the risk of high blood pressure, women with PM had a significantly higher risks of increased waist circumference, decreased high-density lipoprotein, increased risk of high triglycerides, and increased fasting blood glucose. Conclusions: The results of this study provided data that can be applied to policies or interventions to prevent or manage metabolic syndrome in women with PM in Korea.

• 대한지역사회영양학회지
• /
• 제15권3호
• /
• pp.403-414
• /
• 2010

Reducing women's bone mineral density (BMD) has close relationship to risk in osteoporosis. This study was carried out to identify bone density risk factors affecting women's BMD, and to analyze the relationship of age, between BMD and menopause, BMI, blood pressure lifestyle and dietary habits for bone health by physical measurement and questionnaires. The study subjects, 128 women living in Seoul, were divided into 4 age group; 30~39 years (17), 40~49 years (54) and 50~59 years (36) and 60~69 years (21). There were significant differences in mean height, BMI, systolic blood pressure, menache and menopause age and menopause ratio and BMD T-score among the 4 age groups. BHD was significantly decreased according to increasing age and BMI and menopause. The rate of BMD risk subjects was significantly different increasing with age and BMI. The rate of risk group were 0%, 13%, 22.2% and 71.4%, by age groups and 0%, 16.2%, 33.3% and 52.9% by BMI respectively. BMD of menopause groups was significantly decreased from 1.23 (40 years) to 1.34 (60 years). p < 0.001. Also systolic blood pressure were significantly increased from 116.5 mmHg (30 years) to 130.81 mmHg (60 years). The T-score of normal group also decreased significantly from 1.27 to 0.13 (60years) with age. There were significant negative correlation between BMD and age (r = -0.409) menopause (r = -0.346), BMI (r = -0.218) systolic blood pressure (r = -0.193), salty taste eating out (r = -0.185) (p < 0.05). There were significant positive correlation between BMD and meat fish and walking time. In conclusion, bone density decreased with age. Most of the 50 years' subjects were in risk group. BMI, menopause, systolic blood pressure, frequency alcohol consuming. To prevent osteoporosis, over 40 years needed to be educated to maintain normal weight and the improvement of eating and living habits.

• 근관절건강학회지
• /
• 제30권2호
• /
• pp.83-92
• /
• 2023

Purpose: This study aims to compare and analyze the changes in the physical and mental health status of middle-aged women before and after menopause and their quality of life over the past 10 years. Methods: A descriptive study was conducted by using secondary data from the 4th and 7th Korea National Health and Nutrition Examination Survey (KNHANES) involving middle-aged women in menopause (N=8,363). Data were analyzed using the complex sample x² test. Results: Compared to 10 years ago, notable changes were observed in general characteristics. These included increase in age, education level, economic activity, and urban residency. In addition, there was an increase in alcohol consumption, a decrease in smoking, and a decline in regular exercise. The study also observed changes in obesity rates and an increase in dyslipidemia and stress levels, along with positive changes across all aspects of quality of life. Conclusion: The results indicate temporal changes in general characteristics, major physical and mental health factors, and the quality of life of middle-aged women in menopause. Thus, it is essential to consider these changes when designing health interventions such as health promotions and education initiatives for middle-aged women experiencing menopause. Further research is necessary for identifying factors influencing the quality of life of middle-aged women in menopause.

• 산업융합연구
• /
• 제21권6호
• /
• pp.81-90
• /
• 2023

본 연구는 한국에 거주하는 중년기 결혼이주여성의 폐경 경험을 확인하기 위하여 시도되었다. 연구참여자는 15년 이상 한국에서 거주한 만 45세 이상의 폐경이 된 6명의 결혼이주여성이었다. 자료수집은 2023년 2월 27일부터 2023년 4월 20일까지 비구조적이고 개방적인 질문을 통해 심층면담을 하였다. 수집된 자료는 Downe-Wambolt (1992)가 제시한 내용분석방법을 이용하여 분석하였다. 분석된 결과로 4개의 범주와 10개의 하위범주로 도출되었다. 4개의 범주는 폐경 후 다양한 변화로 힘들어함, 폐경 증상을 극복하려고 노력함, 폐경이 긍정적으로 다가옴, 폐경을 수동적으로 받아들임이었다. 중년기 결혼이주여성을 위한 개별적인 간호 접근뿐만 아니라 개인의 사회문화적 맥락을 고려한 총체적 간호가 필요함을 확인할 수 있었다.

• Journal of Ginseng Research
• /
• 제37권1호
• /
• pp.30-36
• /
• 2013

The aim of this review was to assess the effectiveness of ginseng as a treatment option for managing menopause symptoms. We searched the literature using ll databases from their inception to 26 September 2012 and included all randomised clinical trials (RCTs) that compared any type of ginseng to a placebo controls in postmenopausal women. The methodological quality of all studies was assessed using a Cochrane risk of bias tool. Four RCTs met our inclusion criteria. Most RCTs had high risk of bias. One RCT showed that Korean red ginseng (KRG) significantly improved sexual arousal and global health compared with placebo. Another RCT reported the superiority of KRG over placebo for treating menopause symptoms on Kupperman's index and menopausal rating score. The third RCT failed to show a significant effect of KRG on hot flash frequency compared to placebo. The fourth RCT found beneficial effects of ginseng compared to placebo on depression and well-being. In conclusion, the evidence on ginseng as an effective treatment for managing menopause symptoms is limited. Most of the RCTs are burdened with a high risk of bias. Thus firm conclusions cannot be drawn. Rigorous studies seem warranted.